7 new results for Hepatitis C Articles

[Guest guest]

News

7 new results for Hepatitis

Vertex Licensing Pact With Alios Expands Hepatitis Pipeline

Wall Street Journal

Vertex Pharmaceuticals Inc. (VRTX) reached an exclusive global licensing

agreement with biotechnology firm Alios BioPharma Inc. at an initial cost of $60

million, which will add two compounds to Vertex's pipeline of potential

hepatitis C treatments. ...

See all stories on this topic »

Massive Opportunity Exists in Hepatitis C Market for Recently Approved ...

Business Wire (press release)

and Incivek (telaprevir by Vertex/ & /Mitsubishi Tanabe Pharma)

suggest that uptake of the new protease inhibitors will be rapid and that a

significant proportion of Hepatitis C (HCV) patients have been delaying

treatment in anticipation ...

See all stories on this topic »

Coffee May Help In Fight Against Hepatitis

RTT News

Research showed drinking three or more cups per day helped advanced hepatitis C

patients with chronic liver disease respond to a treatment. These results can be

found in " Gastroenterology, " the official journal of the American

Gastroenterological ...

See all stories on this topic »

Hepatitis E sounds alarm

Bangladesh News 24 hours

The warning followed the lab confirmation of hepatitis E outbreak in the

Kumudini Welfare Trust's Mirzapur complex in Tangail, a neighbourhood of the

capital Dhaka. A number of students residing in dormitories of the Kumudini

Medical College and ...

See all stories on this topic »

Vertex And Merck Introduces New Hepatitis C Drug

allvoices

By sylar87 The Food and Drug Administration (FDA) last month approved two new

Hepatitis C drugs of Merck Company and Vertex Pharmaceuticals and &

's under the name Victrelis and Incivek respectively. Hepatitis C is

basically an ...

See all stories on this topic »

New Hepatitis C Drugs to their HEPVisionsSM Therapy Management Program

The Open Press (press release)

(OPENPRESS) June 14, 2011 -- The announcement comes on the heels of the FDA's

approval of Merck's VictrelisTM and Vertex's IncivekTM. Both drugs are approved

for use in combination with peg interferon and ribavirin, creating a triple

therapy regimen. ...

See all stories on this topic »

Hepatitis C-Infected Patients Have High Mortality from All Causes

MedIndia

by Kathy on June 13, 2011 at 9:46 PM Mortality from all causes is higher

in those infected with hepatitis C, a new study has found. Liver-related

mortality among those infected with hepatitis C is well known, but little is

known about deaths in ...

See all stories on this topic »

[Guest guest]

News

7 new results for Hepatitis

Vertex Licensing Pact With Alios Expands Hepatitis Pipeline

Wall Street Journal

Vertex Pharmaceuticals Inc. (VRTX) reached an exclusive global licensing

agreement with biotechnology firm Alios BioPharma Inc. at an initial cost of $60

million, which will add two compounds to Vertex's pipeline of potential

hepatitis C treatments. ...

See all stories on this topic »

Massive Opportunity Exists in Hepatitis C Market for Recently Approved ...

Business Wire (press release)

and Incivek (telaprevir by Vertex/ & /Mitsubishi Tanabe Pharma)

suggest that uptake of the new protease inhibitors will be rapid and that a

significant proportion of Hepatitis C (HCV) patients have been delaying

treatment in anticipation ...

See all stories on this topic »

Coffee May Help In Fight Against Hepatitis

RTT News

Research showed drinking three or more cups per day helped advanced hepatitis C

patients with chronic liver disease respond to a treatment. These results can be

found in " Gastroenterology, " the official journal of the American

Gastroenterological ...

See all stories on this topic »

Hepatitis E sounds alarm

Bangladesh News 24 hours

The warning followed the lab confirmation of hepatitis E outbreak in the

Kumudini Welfare Trust's Mirzapur complex in Tangail, a neighbourhood of the

capital Dhaka. A number of students residing in dormitories of the Kumudini

Medical College and ...

See all stories on this topic »

Vertex And Merck Introduces New Hepatitis C Drug

allvoices

By sylar87 The Food and Drug Administration (FDA) last month approved two new

Hepatitis C drugs of Merck Company and Vertex Pharmaceuticals and &

's under the name Victrelis and Incivek respectively. Hepatitis C is

basically an ...

See all stories on this topic »

New Hepatitis C Drugs to their HEPVisionsSM Therapy Management Program

The Open Press (press release)

(OPENPRESS) June 14, 2011 -- The announcement comes on the heels of the FDA's

approval of Merck's VictrelisTM and Vertex's IncivekTM. Both drugs are approved

for use in combination with peg interferon and ribavirin, creating a triple

therapy regimen. ...

See all stories on this topic »

Hepatitis C-Infected Patients Have High Mortality from All Causes

MedIndia

by Kathy on June 13, 2011 at 9:46 PM Mortality from all causes is higher

in those infected with hepatitis C, a new study has found. Liver-related

mortality among those infected with hepatitis C is well known, but little is

known about deaths in ...

See all stories on this topic »